Surrozen, Inc./DE financial data

Symbol
SRZN, SRZNW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
171 Oyster Point Blvd, Suite 400, South San Francisco, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Consonance-HFW Acquisition Corp. (to 8/11/2021)
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 677 % -27.9%
Debt-to-equity 19 % +10.1%
Return On Equity -89.1 % -61.1%
Return On Assets -74.9 % -58.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.2M shares -89.4%
Common Stock, Shares, Outstanding 2.11M shares -93%
Entity Public Float 11.5M USD -84.9%
Common Stock, Value, Issued 0 USD -100%
Weighted Average Number of Shares Outstanding, Basic 30.5M shares -12.8%
Weighted Average Number of Shares Outstanding, Diluted 30.5M shares -12.8%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 24.4M USD -31.7%
General and Administrative Expense 14.4M USD -28.1%
Operating Income (Loss) -40.3M USD +9.27%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -37.6M USD +11.3%
Earnings Per Share, Basic -18.4 USD/shares +18.1%
Earnings Per Share, Diluted -18.4 USD/shares +18.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 27.3M USD -1.87%
Marketable Securities, Current 0 USD -100%
Cash, Cash Equivalents, and Short-term Investments 27.3M USD -55.8%
Accounts Receivable, after Allowance for Credit Loss, Current 2.13M USD +7.58%
Assets, Current 32M USD -52.2%
Property, Plant and Equipment, Net 1.58M USD -53.1%
Operating Lease, Right-of-Use Asset 1.53M USD -48.4%
Other Assets, Noncurrent 897K USD +116%
Assets 36.7M USD -50.5%
Accounts Payable, Current 131K USD -23.4%
Accrued Liabilities, Current 3.49M USD -34.5%
Liabilities, Current 6.18M USD -20.7%
Operating Lease, Liability, Noncurrent 223K USD -92%
Liabilities 6.58M USD -41.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -231M USD -19.5%
Stockholders' Equity Attributable to Parent 30.1M USD -52.2%
Liabilities and Equity 36.7M USD -50.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.75M USD +38.3%
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities 51.7M USD +35%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 2.11M shares -93%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.75M USD -381%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 28M USD -0.84%
Deferred Tax Assets, Valuation Allowance 54M USD +19%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 54.4M USD +18%
Operating Lease, Liability 2.79M USD -45.1%
Payments to Acquire Property, Plant, and Equipment 7K USD -97.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -37.5M USD +10.6%
Lessee, Operating Lease, Liability, to be Paid 2.91M USD -47.4%
Property, Plant and Equipment, Gross 9.34M USD -37.7%
Operating Lease, Liability, Current 2.56M USD +11.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 891K USD -66.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 891K USD -66.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 119K USD -73.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 891K USD -66.6%
Deferred Tax Assets, Operating Loss Carryforwards 36.4M USD +10.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 1.73M USD +5.96%
Operating Lease, Payments 2.6M USD -5.36%
Additional Paid in Capital 261M USD +1.81%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 449K USD -42.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%